158 related articles for article (PubMed ID: 10844916)
1. Value of predictive genetic testing in management of hereditary non-polyposis colorectal cancer (HNPCC).
Stanley AJ; Gaff CL; Aittomäki AK; Fabre LC; Macrae FA; St John J
Med J Aust; 2000 Apr; 172(7):313-6. PubMed ID: 10844916
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetics improves the management of hereditary non-polyposis colorectal cancer.
Ramesar RS; Madden MV; Felix R; Harocopos CJ; Westbrook CA; Jones G; Cruse JP; Goldberg PA
S Afr Med J; 2000 Jul; 90(7):709-14. PubMed ID: 10985134
[TBL] [Abstract][Full Text] [Related]
3. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
[TBL] [Abstract][Full Text] [Related]
4. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study.
Dove-Edwin I; Sasieni P; Adams J; Thomas HJ
BMJ; 2005 Nov; 331(7524):1047. PubMed ID: 16243849
[TBL] [Abstract][Full Text] [Related]
5. Predictive genetic testing of first degree relatives of mutation carriers is a cost-effective strategy in preventing hereditary non-polyposis colorectal cancer in Singapore.
Wang VW; Koh PK; Chow WL; Lim JF
Fam Cancer; 2012 Jun; 11(2):279-89. PubMed ID: 22350504
[TBL] [Abstract][Full Text] [Related]
6. The management of families affected by hereditary non-polyposis colorectal cancer (HNPCC).
Geary J; Thomas HJ; Mackay J; Dorkins H; Barwell J; Hodgson SV
Fam Cancer; 2007; 6(1):13-9. PubMed ID: 16937234
[TBL] [Abstract][Full Text] [Related]
7. Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations.
Halbert CH; Lynch H; Lynch J; Main D; Kucharski S; Rustgi AK; Lerman C
Arch Intern Med; 2004 Sep; 164(17):1881-7. PubMed ID: 15451763
[TBL] [Abstract][Full Text] [Related]
8. Clinical identification and long-term surveillance of 22 hereditary non-polyposis colon cancer Italian families.
Arrigoni A; Sprujevnik T; Alvisi V; Rossi A; Ricci G; Pennazio M; Spandre M; Cavallero M; Bertone A; Foco A; Rossini FP
Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):213-9. PubMed ID: 15674100
[TBL] [Abstract][Full Text] [Related]
9. Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures.
Wagner A; van Kessel I; Kriege MG; Tops CM; Wijnen JT; Vasen HF; van der Meer CA; van Oostrom II; Meijers-Heijboer H
Fam Cancer; 2005; 4(4):295-300. PubMed ID: 16341806
[TBL] [Abstract][Full Text] [Related]
10. [Current concepts in the genetics of hereditary and sporadic colorectal cancer and the role of genetics in patient management. Hereditary colorectal cancers].
Lakatos PL; Lakatos L
Orv Hetil; 2006 Feb; 147(8):363-8. PubMed ID: 16579336
[TBL] [Abstract][Full Text] [Related]
11. Hereditary nonpolyposis colorectal cancer: preventive management.
Annie Yu HJ; Lin KM; Ota DM; Lynch HT
Cancer Treat Rev; 2003 Dec; 29(6):461-70. PubMed ID: 14585257
[TBL] [Abstract][Full Text] [Related]
12. Hereditary non-polyposis colorectal cancer (HNPCC): new germline mutation (190-191 del AA) in the human MLH1 gene and review of clinical guidelines for surveillance of affected families.
Schiemann U; Papatheodorou L; Glasl S; Gross M
Eur J Med Res; 2001 Mar; 6(3):93-100. PubMed ID: 11309221
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer.
Engel C; Rahner N; Schulmann K; Holinski-Feder E; Goecke TO; Schackert HK; Kloor M; Steinke V; Vogelsang H; Möslein G; Görgens H; Dechant S; von Knebel Doeberitz M; Rüschoff J; Friedrichs N; Büttner R; Loeffler M; Propping P; Schmiegel W;
Clin Gastroenterol Hepatol; 2010 Feb; 8(2):174-82. PubMed ID: 19835992
[TBL] [Abstract][Full Text] [Related]
14. Decentralized colonoscopic surveillance with high patient compliance prevents hereditary and familial colorectal cancer.
Sjöström O; Lindholm L; Tavelin B; Melin B
Fam Cancer; 2016 Oct; 15(4):543-51. PubMed ID: 26935832
[TBL] [Abstract][Full Text] [Related]
15. The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome.
Kang YJ; Killen J; Caruana M; Simms K; Taylor N; Frayling IM; Snowsill T; Huxley N; Coupe VM; Hughes S; Freeman V; Boussioutas A; Trainer AH; Ward RL; Mitchell G; Macrae FA; Canfell K
Med J Aust; 2020 Feb; 212(2):72-81. PubMed ID: 31595523
[TBL] [Abstract][Full Text] [Related]
16. Hereditary colorectal cancer: clinical consequences of predictive molecular testing.
Hahn M; Saeger HD; Schackert HK
Int J Colorectal Dis; 1999 Nov; 14(4-5):184-93. PubMed ID: 10647626
[TBL] [Abstract][Full Text] [Related]
17. Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma.
Collins V; Meiser B; Gaff C; St John DJ; Halliday J
Cancer; 2005 Jul; 104(2):273-81. PubMed ID: 15948171
[TBL] [Abstract][Full Text] [Related]
18. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.
Loughrey MB; Waring PM; Tan A; Trivett M; Kovalenko S; Beshay V; Young MA; McArthur G; Boussioutas A; Dobrovic A
Fam Cancer; 2007; 6(3):301-10. PubMed ID: 17453358
[TBL] [Abstract][Full Text] [Related]
19. Direct mutational analysis in a family with hereditary non-polyposis colorectal cancer.
Van de Water NS; Jeevaratnam P; Browett PJ; Stewart SM; Lane MR; Jass JR
Aust N Z J Med; 1994 Dec; 24(6):682-6. PubMed ID: 7717919
[TBL] [Abstract][Full Text] [Related]
20. Screening results in a family cancer clinic: five years experience.
Hodgson SV; Harocopos C; Gaglia P
Anticancer Res; 1993; 13(6B):2581-5. PubMed ID: 8135498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
